Afogatran 110 Capsule

CARDIAC • Direct thrombin inhibitor- oral

⚠️ Schedule H/H1: Prescription required. Do not self-medicate.

1. Clinical Overview

Afogatran 110 Capsule contains Dabigatran (110 mg), a direct thrombin inhibitor used as an anticoagulant to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for treatment of deep vein thrombosis and pulmonary embolism. It works by directly inhibiting thrombin. Swallow whole, do not open. Take with food to reduce dyspepsia.

ManufacturerFormPack Size
Torrent Pharmaceuticals Ltdallopathystrip of 10 capsules

2. Side Effects

Possible side effects associated with Afogatran 110 Capsule:

  • Common side effects include bleeding (e.g.
  • nosebleeds
  • gum bleeding
  • easy bruising)
  • dyspepsia
  • and abdominal pain. Less common side effects include anemia
  • nausea
  • and diarrhea. Serious side effects include major bleeding (e.g.
  • intracranial
  • gastrointestinal)
  • which may be fatal. Avoid with mechanical heart valves. Use with caution in renal impairment.

4. Trusted Substitutes (Same Salt)

Medicines with the same composition (Dabigatran Etexilate (110mg)):

Brand NameManufacturerAction
Bigatra 110mg TabletAprica Pharmaceuticals Pvt LtdView Details
Dabigo 110mg CapsuleSun Pharmaceutical Industries LtdView Details
Dabistar 110 CapsuleLupin LtdView Details
Dabiclot 110 CapsuleAlkem Laboratories LtdView Details
Dabigat 110 CapsuleNatco Pharma LtdView Details
Dablexa 110 CapsuleAbbottView Details